ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

Cost To Oncologist For Enrolling a Patient On Trial About $2,000, ASCO Survey Finds

June 11, 1999

Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC

September 10, 1982

Surgery Improves Survival For Women With Metastatic Breast Cancer At Diagnosis

May 26, 2006

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006